Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LIXT
#3813
Lixte Biotechnology Holdings, Inc. Common Stock
2.9
0
-2.68%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-2.68%
Variazione Mensile
-15.20%
Variazione di 6 mesi
-15.20%
Variazione Annuale
+110.14%
Chiusura Precedente
2.9
8
Open
2.8
9
Bid
Ask
Low
2.8
5
High
2.9
4
Volume
20
Mercati
Mercato Azionario Statunitense
Salute
LIXT
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
2.25 M
2.68 M
2.68 M
4.56 M
5.7 M
—
Valuation ratios
Enterprise value
6.07 M
8.7 M
5.36 M
3.24 M
28.36 M
45.66 M
Price to earnings ratio
-1.12
-1.28
-0.83
-0.7
-4.26
-7.08
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-1.16
-1.44
-0.94
-0.82
-6.09
-9.3
Price to book ratio
-1.32
-1.71
-0.33
-0.32
-3.32
-5.68
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.58
-0.54
-0.47
-0.65
-0.36
-2.02
Return on equity %
-0.72
-0.75
-0.61
-1.19
-0.4
-2.95
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.13
1.12
4.26
1.84
10.42
17.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.43
-0.27
-0.23
-0.19
-0.24
-0.93
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.73
0.11
0.56
0.34
0.76
1.77
Net current asset value per share
0.75
0.16
0.61
0.38
1.43
2.58
Tangible book value per share
-0.95
-1.19
-0.95
0.25
0.62
-1.26
Working capital per share
0.6
0.02
0.47
0.17
1.29
1.95
Book value per share
-0.95
-1.19
-0.95
0.25
0.62
-1.26
Notizie
LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary
LIXTE expands clinical trial for ovarian cancer treatment
Lixte生物科技在430万美元直接发行后股价下跌
斯巴达资本担任Lixte 430万美元融资的配售代理
Lixte Biotechnology stock falls after $4.3 million direct offering
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering
Lixte生物科技股价在430万美元直接融资后下跌
Lixte Biotechnology stock falls after $4.3 million direct offering
Lixte Biotechnology raises $4.3 million in registered direct offering
Lixte生物科技股东批准董事会提名人选和股票计划修订案
Lixte Biotechnology shareholders approve board nominees and stock plan amendment
Lixte生物科技股价在收购英国Liora后下跌